A detailed history of Geode Capital Management, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,525,816 shares of TNDM stock, worth $49.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,525,816
Previous 1,507,629 1.21%
Holding current value
$49.6 Million
Previous $60.7 Million 6.51%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$35.21 - $47.3 $640,364 - $860,245
18,187 Added 1.21%
1,525,816 $64.7 Million
Q2 2024

Aug 09, 2024

BUY
$30.43 - $53.43 $13.1 Million - $23.1 Million
431,532 Added 40.1%
1,507,629 $60.7 Million
Q1 2024

May 13, 2024

BUY
$22.09 - $35.41 $804,296 - $1.29 Million
36,410 Added 3.5%
1,076,097 $38.1 Million
Q4 2023

Feb 13, 2024

BUY
$14.28 - $31.03 $576,569 - $1.25 Million
40,376 Added 4.04%
1,039,687 $30.8 Million
Q3 2023

Nov 13, 2023

BUY
$19.33 - $36.22 $501,787 - $940,234
25,959 Added 2.67%
999,311 $20.8 Million
Q2 2023

Aug 11, 2023

BUY
$24.18 - $42.46 $886,801 - $1.56 Million
36,675 Added 3.92%
973,352 $23.9 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $800,000 - $1.04 Million
22,309 Added 2.44%
936,677 $38 Million
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $1.72 Million - $2.72 Million
48,375 Added 5.59%
914,368 $41.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $484,073 - $762,946
11,062 Added 1.29%
865,993 $41.4 Million
Q2 2022

Aug 12, 2022

BUY
$53.22 - $123.09 $36,615 - $84,685
688 Added 0.08%
854,931 $50.6 Million
Q1 2022

May 13, 2022

BUY
$101.89 - $150.09 $3.1 Million - $4.57 Million
30,445 Added 3.7%
854,243 $99.3 Million
Q4 2021

Feb 11, 2022

BUY
$118.18 - $153.21 $2.69 Million - $3.48 Million
22,743 Added 2.84%
823,798 $124 Million
Q3 2021

Nov 12, 2021

BUY
$93.51 - $129.4 $1.03 Million - $1.43 Million
11,050 Added 1.4%
801,055 $95.6 Million
Q2 2021

Aug 13, 2021

BUY
$77.0 - $100.19 $975,744 - $1.27 Million
12,672 Added 1.63%
790,005 $76.9 Million
Q1 2021

May 12, 2021

BUY
$81.28 - $104.34 $2.53 Million - $3.25 Million
31,160 Added 4.18%
777,333 $68.6 Million
Q4 2020

Feb 12, 2021

BUY
$86.4 - $121.75 $5.07 Million - $7.15 Million
58,692 Added 8.54%
746,173 $71.4 Million
Q3 2020

Nov 13, 2020

SELL
$95.43 - $116.09 $638,426 - $776,642
-6,690 Reduced 0.96%
687,481 $78 Million
Q2 2020

Aug 13, 2020

SELL
$60.05 - $98.92 $11.6 Million - $19.1 Million
-193,489 Reduced 21.8%
694,171 $68.7 Million
Q1 2020

May 14, 2020

BUY
$47.37 - $90.04 $387,155 - $735,896
8,173 Added 0.93%
887,660 $57.1 Million
Q4 2019

Feb 13, 2020

SELL
$53.13 - $71.19 $1.14 Million - $1.52 Million
-21,395 Reduced 2.37%
879,487 $52.4 Million
Q3 2019

Nov 12, 2019

BUY
$57.11 - $73.3 $3.62 Million - $4.64 Million
63,344 Added 7.56%
900,882 $53.1 Million
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $6.31 Million - $8.31 Million
115,899 Added 16.06%
837,538 $54 Million
Q1 2019

May 14, 2019

BUY
$32.25 - $73.56 $2.39 Million - $5.45 Million
74,045 Added 11.43%
721,639 $45.8 Million
Q4 2018

Feb 13, 2019

BUY
$28.45 - $40.65 $1.76 Million - $2.52 Million
61,922 Added 10.57%
647,594 $24.6 Million
Q3 2018

Nov 13, 2018

BUY
$21.39 - $51.17 $3.98 Million - $9.52 Million
186,134 Added 46.59%
585,672 $25.1 Million
Q2 2018

Aug 14, 2018

BUY
$4.9 - $23.64 $709,946 - $3.43 Million
144,887 Added 56.9%
399,538 $8.8 Million
Q1 2018

May 15, 2018

BUY
$2.35 - $4.96 $558,489 - $1.18 Million
237,655 Added 1398.3%
254,651 $1.26 Million
Q4 2017

Feb 13, 2018

SELL
$2.24 - $8.2 $366,390 - $1.34 Million
-163,567 Reduced 90.59%
16,996 $40,000
Q3 2017

Nov 14, 2017

BUY
$3.9 - $10.1 $704,195 - $1.82 Million
180,563
180,563 $131,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.09B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.